Skip to content
TrialScanner

NCT04245176

Genetic Testing for All Breast Cancer Patients (GET FACTS)

No phase registeredCompletedMYGNCollaborator

Registry record

Lead sponsor
Brigham and Women's Hospital
Conditions
Breast Cancer; Invasive Breast Cancer; in Situ Breast Cancer; Genetic Testing
Primary completion
Dec 1, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04245176 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04245176: Genetic Testing for All... | TrialScanner